Introduction Chlorpromazine has been suggested as being potentially useful in patients with
coronavirus disease 2019 (COVID-19) on the grounds of its potential antiviral and anti …

Background Hydroxychloroquine has been widely administered to patients with Covid-19
without robust evidence supporting its use. Methods We examined the association between …

There is both uncertainty regarding the safety of clozapine in COVID-19 patients owing to
limited published data and a lack of consensus on continuing clozapine in patients with …

Background Hydroxychloroquine and chloroquine have been proposed as treatments for
coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from …

Background: Bromhexine is a potent inhibitor of transmembrane serine protease 2 and
appears to have an antiviral effect in controlling influenza and parainfluenza infection; …

The interaction of coronavirus disease (COVID‐19) with the majority of common
prescriptions is broadly unknown. The purpose of this study is to identify medications …

Background Haloperidol, a widely used antipsychotic, has been suggested as potentially
useful for patients with COVID-19 on the grounds of its in-vitro antiviral effects against SARS …

Importance Hydroxychloroquine, with or without azithromycin, has been considered as a
possible therapeutic agent for patients with coronavirus disease 2019 (COVID-19) …

Abstract Significance The United States is in an acceleration phase of the COVID-19
pandemic. Currently there is no known effective therapy or vaccine for treatment of SARS …

Methods: An open-label randomized clinical trial study was performed in Tabriz, North-West
of Iran. They were randomized to either the treatment with the bromhexine group or the …